nicotine has been researched along with l 663536 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, C; Fadda, P; Fratta, W; Goldberg, SR; Justinova, Z; Le Foll, B; Lecca, S; Luchicchi, A; Mascia, P; Panlilio, LV; Piomelli, D; Pistis, M; Redhi, GH; Scherma, M; Tanda, G; Yasar, S | 1 |
Adair, J; Aliczki, M; Barnes, C; Goldberg, SR; Haller, J; Heishman, SJ; Justinova, Z; Lecca, S; Luchicchi, A; Mascia, P; Panlilio, LV; Pistis, M; Redhi, GH; Yasar, S | 1 |
2 other study(ies) available for nicotine and l 663536
Article | Year |
---|---|
Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors.
Topics: Action Potentials; Animals; Behavior, Animal; Conditioning, Operant; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Indoles; Male; Microdialysis; Neurons; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Oligosaccharides; Peroxisome Proliferators; PPAR alpha; Pyrimidines; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Reward; Saimiri; Self Administration; Ventral Tegmental Area | 2011 |
Novel use of a lipid-lowering fibrate medication to prevent nicotine reward and relapse: preclinical findings.
Topics: Action Potentials; Animals; Clofibrate; Disease Models, Animal; Dopamine; Drug Evaluation, Preclinical; Hypolipidemic Agents; Indoles; Male; Neurons; Nicotine; Nucleus Accumbens; PPAR alpha; Rats; Rats, Sprague-Dawley; Reward; Saimiri; Secondary Prevention; Self Administration; Tobacco Use Disorder; Ventral Tegmental Area | 2012 |